Martha Shackleton

412 total citations
10 papers, 331 citations indexed

About

Martha Shackleton is a scholar working on Ophthalmology, Molecular Biology and Pharmacology. According to data from OpenAlex, Martha Shackleton has authored 10 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Ophthalmology, 2 papers in Molecular Biology and 2 papers in Pharmacology. Recurrent topics in Martha Shackleton's work include Glaucoma and retinal disorders (6 papers), Retinal Diseases and Treatments (4 papers) and Drug-Induced Ocular Toxicity (3 papers). Martha Shackleton is often cited by papers focused on Glaucoma and retinal disorders (6 papers), Retinal Diseases and Treatments (4 papers) and Drug-Induced Ocular Toxicity (3 papers). Martha Shackleton collaborates with scholars based in Ireland and United States. Martha Shackleton's co-authors include Andrew Acheampong, Diane Tang‐Liu, D. Tang–Liu, J. Burke, B. A. John, Larry A. Wheeler, Robert S. Decker, Janet A. Anderson, Wendy Luo and Janet K. Anderson and has published in prestigious journals such as Journal of Pharmaceutical Sciences, Drug Metabolism and Disposition and Advances in experimental medicine and biology.

In The Last Decade

Martha Shackleton

10 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martha Shackleton Ireland 9 197 129 88 78 74 10 331
Efraim Duzman United States 14 334 1.7× 161 1.2× 70 0.8× 65 0.8× 43 0.6× 28 464
Milton T. Brady United States 8 176 0.9× 144 1.1× 59 0.7× 65 0.8× 18 0.2× 10 451
Irving M. Katz United States 8 302 1.5× 107 0.8× 88 1.0× 65 0.8× 38 0.5× 8 389
Norhafiza Razali Malaysia 7 128 0.6× 103 0.8× 55 0.6× 115 1.5× 105 1.4× 13 329
Rossella Giannotti Italy 7 94 0.5× 42 0.3× 61 0.7× 121 1.6× 15 0.2× 11 323
Kathleen Fillacier France 4 415 2.1× 291 2.3× 231 2.6× 60 0.8× 7 0.1× 6 518
Tom R. Walters United States 4 175 0.9× 84 0.7× 39 0.4× 28 0.4× 12 0.2× 5 228
Yoshinao Majima Japan 12 96 0.5× 31 0.2× 69 0.8× 149 1.9× 13 0.2× 30 357
Minerva Batugo United States 6 112 0.6× 41 0.3× 40 0.5× 81 1.0× 12 0.2× 7 219
Thorsten R. Stolwijk Netherlands 9 344 1.7× 303 2.3× 205 2.3× 33 0.4× 19 0.3× 12 431

Countries citing papers authored by Martha Shackleton

Since Specialization
Citations

This map shows the geographic impact of Martha Shackleton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martha Shackleton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martha Shackleton more than expected).

Fields of papers citing papers by Martha Shackleton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martha Shackleton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martha Shackleton. The network helps show where Martha Shackleton may publish in the future.

Co-authorship network of co-authors of Martha Shackleton

This figure shows the co-authorship network connecting the top 25 collaborators of Martha Shackleton. A scholar is included among the top collaborators of Martha Shackleton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martha Shackleton. Martha Shackleton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Acheampong, Andrew, Martha Shackleton, B. A. John, et al.. (2002). Distribution of Brimonidine into Anterior and Posterior Tissues of Monkey, Rabbit, and Rat Eyes. Drug Metabolism and Disposition. 30(4). 421–429. 97 indexed citations
2.
Acheampong, Andrew, et al.. (1999). Distribution of cyclosporin A in ocular tissues after topical administration to albino rabbits and beagle dogs. Current Eye Research. 18(2). 91–103. 64 indexed citations
3.
Acheampong, Andrew, et al.. (1998). Cyclosporine Distribution into the Conjunctiva, Cornea, Lacrimal Gland, and Systemic Blood Following Topical Dosing of Cyclosporine to Rabbit, Dog, and Human Eyes. Advances in experimental medicine and biology. 30(1). 1001–1004. 12 indexed citations
5.
Acheampong, Andrew, et al.. (1995). Comparison of Concentration-Time Profiles of Levobunolol and Timolol in Anterior and Posterior Ocular Tissues of Albino Rabbits. Journal of Ocular Pharmacology and Therapeutics. 11(4). 489–502. 27 indexed citations
6.
Acheampong, Andrew, Martha Shackleton, & D. Tang–Liu. (1995). Comparative ocular pharmacokinetics of brimonidine after a single dose application to the eyes of albino and pigmented rabbits.. Drug Metabolism and Disposition. 23(7). 708–712. 65 indexed citations
7.
Koda, Robert T., et al.. (1988). The Ocular Distribution of Bunolol in the Eyes of Albino and Pigmented Rabbits. Journal of Ocular Pharmacology and Therapeutics. 4(1). 37–42. 9 indexed citations
8.
Tang‐Liu, Diane, et al.. (1988). Ocular Metabolism of Levobunolol. Journal of Ocular Pharmacology and Therapeutics. 4(3). 269–278. 8 indexed citations
9.
Anderson, Janet K., et al.. (1987). The Disposition of Bunolol in the Rabbit Eye. Journal of Ocular Pharmacology and Therapeutics. 3(2). 149–157. 11 indexed citations
10.
Anderson, Janet A., et al.. (1982). Disposition of Topical Flurbiprofen in Normal and Aphakic Rabbit Eyes. Archives of Ophthalmology. 100(4). 642–645. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026